NCI-H1793 Cells
USD$550.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | NCI-H1793 is a human non-small cell lung cancer (NSCLC) cell line derived from an adult patient with lung adenocarcinoma. The cells exhibit epithelial morphology and grow adherently in standard tissue culture conditions. As a representative model of pulmonary adenocarcinoma, NCI-H1793 retains key molecular and phenotypic characteristics associated with this histological subtype, making it suitable for in vitro studies of lung cancer biology, tumor progression, and therapeutic response. Molecular characterization of NCI-H1793 has identified an activating mutation in the KRAS oncogene (G12C), a common driver alteration in lung adenocarcinoma. This mutation results in constitutive activation of downstream signaling pathways, including the MAPK and PI3K-AKT cascades, promoting proliferation and survival. The presence of KRAS G12C makes NCI-H1793 particularly valuable for investigating RAS-driven oncogenic signaling and for evaluating targeted inhibitors directed against mutant KRAS or its downstream effectors. The cell line has also been reported to harbor additional genomic alterations typical of NSCLC, supporting its relevance as a preclinical model for molecularly defined lung cancer. Due to its defined oncogenic background and epithelial tumor phenotype, NCI-H1793 is widely used in studies assessing targeted therapies, resistance mechanisms, and combination treatment strategies in KRAS-mutant lung cancer. It serves as a robust platform for functional genomics, drug screening, and pathway analysis aimed at elucidating vulnerabilities in RAS-driven malignancies. |
|---|---|
| Organism | Human |
| Tissue | Lung |
| Disease | Lung adenocarcinoma |
| Synonyms | H1793, H-1793, NCIH1793 |
Characteristics
| Age | 52 years |
|---|---|
| Gender | Female |
| Ethnicity | Caucasian |
| Morphology | epithelial |
| Growth properties | adherent |
Regulatory Data
| Citation | NCI-H1793 (Cytion catalog number 305911) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1496 |
Biomolecular Data
| Mutational profile | Mutation: p.Arg209Ter, Heterozygous; Mutation: p.Arg273His, Heterozygous |
|---|
Handling
| Culture Medium | HITES medium supplementedThe base medium for this cell line is DF12. To make the complete growth medium, add the following components to the base medium:
|
|---|---|
| Dissociation Reagent | Accutase |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305911-151225 | Certificate of Analysis | 05. Mar. 2026 | 305911 |